Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...

DelveInsight’s Thalassemia Market Insights report includes a comprehensive understanding of current treatment practices, emerging thalassemia drugs, market share of individual therapies, and current ...

Beta thalassemia and sickle cell are two red blood cell disorders which both come with massive health implications and shortened lifespans, but at least for UK-based patients the former may soon be ...

Patients with sickle cell disease and beta-thalassemia treated with exagamglogene autotemcel reported substantial and ...

"Beta Thalassemia Market"In 2020, there are more than 900 beta-thalassemia major patients and more than 200 beta-thalassemia intermedia patients living in the UK. Emerging therapies for Beta ...

(MENAFN- GlobeNewsWire - Nasdaq) The thalassemia market is primarily driven by regular blood transfusions and iron chelation therapies, which help manage anemia and prevent iron overload. Curative ...

New York, USA, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Thalassemia Treatment Market to Witness Significant Growth by 2034 Driven by Novel Drug Development | DelveInsight The thalassemia market is primarily ...